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We report the first case of pulmonary tuberculosis
caused by Mycobacterium bovis subsp. caprae in a captive
Siberian tiger, an endangered feline. The pathogen was
isolated from a tracheal aspirate obtained by bron-
choscopy. This procedure provided a reliable in vivo diag-
nostic method in conjunction with conventional and molec-
ular tests for the detection of mycobacteria.
M
ycobacterium bovis, a member of the M. tuberculosis
complex (MTBC), can cause tuberculosis in a wide
range of domestic and wild animals and also in humans
(1,2). Routine differentiation of M. bovis is based on a
number of phenotypic characteristics and biochemical
tests (2). M. bovis shows dysgonic growth on Löwenstein-
Jensen (LJ) medium and has been described as negative for
nitrate reduction and niacin accumulation (2). As a further
criterion for the differentiation of M. bovis, intrinsic resist-
ance to pyrazinamide (PZA) has been described (2).
However, more recently, PZA-susceptible strains of M.
bovis were found in Spain and Germany; these strains were
also characterized by specific molecular techniques (3–5).
As a consequence, M. bovis was split into two subspecies:
M. bovis subsp. bovis, which showed resistance to PZA,
and M. bovis subsp. caprae, which was sensitive to PZA
(6,7). M. bovis subsp. caprae was initially isolated from
sheep and goats in Spain (3,4,7); however, further studies
confirm its infectivity in humans, cattle, and red deer (6,8).
We report the unusual case of a M. bovis subsp. caprae
infection in a captive Siberian tiger. 
Case Report
An 8-year-old male Siberian tiger at the Budapest
Zoological and Botanical Garden had episodes of cough-
ing in October 2001. Because the coughing did not stop in
6 to 7 days, an expectorant (Bisolvon; Boehringer
Ingelheim Vetmed Gmbh., Ingelheim am Rhein, Germany)
was given for 10 days. His condition showed a temporary
improvement; however, after a few weeks, the animal
started coughing again, and his appetite decreased.
Amoxicillin plus clavulanic acid (Amoksiklav; Lek
Animal Health, Ljubljana, Slovenia) and ketoprophen
(Ketofen, Merial, Lyon, France) therapy was given for 7
days. The tiger’s condition did not show any notable
improvement. In addition, in May 2002, the animal’s res-
piratory rate became elevated, he became dyspneic and
emaciated, and his daily activity substantially decreased.
Further antibacterial treatment was administered (cefatrox-
il, Cefa-cure; Intervet, Boxmeer, the Netherlands) during
that month without clinical effect. At that point, the animal
was anesthetized, and tracheoscopy was performed with a
flexible 56-cm bronchoscope (Olympus B3R; Tokyo,
Japan (Figure 1). The examination found a large amount of
purulent mucus in the trachea. Therefore, several tracheal
washings were taken for microbiologic tests by using a
commercially available tracheal suction set (Medinorm
Medizintechnik GmbH, Quierschied, Germany (Figure 1).
A chest radiograph showed a severe and extensive bron-
chointerstitial pattern with cavernous lesions in both lungs. 
Nine days after the specimens were taken, cultures for
mycobacteria showed growth in the broth-based MGIT
960 system (Becton-Dickinson Microbiology Systems,
Sparks, MD). The acid-fast organism that was isolated was
identified as MTBC by the AccuProbe TB assay (Gen-
Probe Inc., San Diego, CA).
Since the tiger had stopped eating and his condition had
dramatically deteriorated, the animal was euthanized and
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Figure 1. Obtaining a tracheal washing of the Siberian tiger by
bronchoscopy.necropsy was performed. Hematoxylin and eosin–stained
histologic sections of the lung segments showed an exten-
sive multifocal infiltration of lymphocytes, histiocytes,
and some scattered multinuclear giant cells within the
framework of proliferated connective tissue and collagen
fibers of the cavernous lesions. Ziehl-Neelsen staining
showed an intracellular accumulation of acid-fast bacteria
in several alveolar macrophages and epithelioid cells.
The keepers of the tiger also underwent pulmonary
radiographs and tuberculin skin testing. Their skin test
results were negative, and clinical or radiologic signs of
tuberculosis were not detected.
Characterization of MTBC Isolate
Colony morphology of the isolated MTBC strain
showed dysgonic growth on LJ medium and
microaerophilic growth on Lebek medium. The strain was
susceptible to PZA (100 µg/mL) and thiophen-2-car-
boxylic acid hydrazide (TCH; 1 µg/mL) and negative for
niacin accumulation and nitrate reduction (9–11).
The genome of the isolate was analyzed for specific
mutations in the pncA, oxyR, and gyrB genes by automat-
ed DNAsequencing, polymerase chain reaction–restriction
fragment length polymorphism (PCR-RFLP) technique,
and spoligotyping as described previously (5,12–16).
Susceptibility of the isolate to PZAwas linked with a wild-
type pncA sequence. In addition, the isolate contained the
M. bovis–specific G-to-A mutation at position 285 in the
oxyR gene and the G-to-A mutation at position 756 in the
gyrB gene. However, spoligotyping showed a pattern with
the absence of spacer sequences 39–43 and 3–16 (Figure
2), and T to G mutation at position 1,311 in the gyrB gene,
characteristic of M. bovis subsp.  caprae,  could also be
detected by DNAsequencing. On the basis of these pheno-
typic and genetic characteristics, the strain was identified
as M. bovis subsp. caprae (3,6,7,17).
Conclusions
MTBC comprises these closely related organisms: M.
tuberculosis; M. africanum;  M. bovis; the vaccine strain,
M. bovis bacillus Calmette-Guérin; and three rarely seen
members,  M. microti,  M. canettii, and the recently
described seal bacillus, M. pinnipedii (17–20).
Differentiation within MTBC is necessary for individual
patient treatment (i.e., inclusion or exclusion of PZA) and
for epidemiologic purposes, especially in areas of the
world where tuberculosis has reached epidemic propor-
tions or wherever the transmission of M. bovis between
animals, animal products, and humans is a problem (10).
The host range of M. bovis is wide, including many ani-
mal species and humans. Carnivores such as large felines
may acquire the infection through the alimentary tract by
eating infected meat (4). Reports of tuberculosis in large
captive or free-living felines are not common (21–26),
however. 
To our knowledge, this case is the first in which tuber-
culosis attributable to M. bovis subsp. caprae was diag-
nosed in a large feline. The rapid and accurate in vivo diag-
nosis of tuberculosis is indispensable in endangered cap-
tive animals such as the Siberian tiger, not only because of
the declining population of this species but also to prevent
the transmission of the disease to other animals. Although
nasal or throat swabs are used most often, we found tra-
cheal washing by bronchoscopy was easy to perform,
rapid, and more adequate than swabs (provided a larger
sample volume from the lower airways) for obtaining clin-
ical specimen for mycobacterial or other microbiologic
tests. 
The rapid diagnosis of tuberculosis is essential for ade-
quate antituberculosis treatment to be started as early as
possible. The effectiveness of antituberculosis therapy in
felines is controversial (27). However, when an endan-
gered animal is involved, early diagnosis of the disease
might help control it in time to save the animal, especially
with the help of a rapid in vivo diagnostic method such as
tracheal washing through bronchoscopy. Tracheal washing
can also be the method of choice to bacteriologically mon-
itor the efficacy of therapy. In this case, the poor appetite
and condition of the animal did not allow survival long
enough for delivery of antituberculosis treatment. The
source of infection could not be conclusively identified ret-
rospectively; infected goat meat (a usual diet of the ani-
mal) is a likely possibility because the tuberculosis-related
control measures are not as strict with goats as with cattle
in Hungary (annual tuberculin skin testing of goats is not
mandatory, for example) (28).
This report indicates that routine differentiation within
the MTBC is indispensable for understanding the epidemi-
ology of tuberculosis and for determining the prevalence,
transmission, and clinical importance of the different
members of the complex.
Dr. Lantos is an assistant professor in the Department of
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Figure 2. Spoligotype patterns of the isolate obtained from the
Siberian tiger: lane 1; spacer sequences 3–16 and 39–43 are
absent); lane 2, control strain Mycobacterium tuberculosis H37Rv
ATCC 27294; lane 3, control strain M. bovis ATCC 19210; lane 4,
M. bovis BCG ATCC 27289.novel diagnostic methods for detecting mycobacterial infections
and identifying mycobacteria.
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